M. Koprowski et al. / Tetrahedron 65 (2009) 4017–4024
4023
737 (w), 701 (w); 31P NMR (CDCl3):
d
23.04; 31P NMR (C6D6):
3.3.4. Dimethyl 2-(benzo[d][1,3]dioxol-5-yl)-2-
oxoethylphosphonate (9b)
d
22.59; 1H NMR (CDCl3):
d
3.383.43 (m, 1H, CH2P(O)), 3.49–3.54
(m,1H, CH2P(O)), 3.75 (d, JPH¼11.2 Hz, 6H, P(O)(OCH3)2), 3.81 (s, 3H,
p-C6H2(OCH3)3), 3.82 (s, 6H, 2ꢂm-C6H2(OCH3)3), 4.48 (s, 2H,
OCH2Ph), 6.01–6.04 (m, 2H, OCH2O), 6.15 (s, 1H, CHOBn), 6.71 (s,
2H, 2ꢂo-C6H2(OCH3)3), 7.10 (s, 1H, Ar–H), 7.28 (s, 1H, Ar–H), 7.28–
A white solid; mp¼78–80 ꢀC (from petroleum ether/ethyl ace-
tate 3:1 v/v); Rf¼0.20 (hexane/ethyl acetate 1:1 v/v), 0.40 (hexane/
ethyl acetate 1:4 v/v); IR (KBr) n
/cmꢁ1: 3434 (br w), 3068 (w), 3031
(w), 2956 (w, O–CH2–O), 2913 (w, O–CH3), 2853 (w, O–CH3), 1668
(s, C]O), 1600 (m), 1496 (m), 1447 (s, C(O)–CH2), 1271 (vs, P]O),
1245 (s), 1061 (s), 1030 (vs, P–O–C), 1005 (s), 927 (m), 901 (m), 872
7.38 (m, 6H, Ar–H, Ph); 1H NMR (C6D6)
d
3.21 (d, JPH¼22.3 Hz, 2H,
CH2P(O)), 3.34 (d, JPH¼11.2 Hz, 3H, P(O)OCH3), 3.37 (d, JPH¼11.3 Hz,
3H, P(O)OCH3), 3.47 (s, 6H, 2ꢂm-C6H2(OCH3)3), 3.83 (s, 3H, p-
C6H2(OCH3)3), 4.61 (s, 2H, OCH2Ph), 5.13–5.22 (m, 2H, OCH2O), 6.57
(s, 1H, CHOBn), 7.08 (s, 2H, 2ꢂo-C6H2(OCH3)3), 7.09–7.21 (m, 3H,
(m), 832 (m), 813 (m); 31P NMR (C6D6):
d
22.81; 1H NMR (C6D6):
d
3.23 (d, J¼22.7 Hz, 2H, CH2P(O)), 3.38 (d, J¼11.0 Hz, 6H,
P(O)(OCH3)2), 5.13 (s, 2H, OCH2O), 6.46 (d, J¼7.4 Hz, 1H, 6-Ar–H),
Ph), 7.25 (s, 1H, Ar), 7.46 (s, 1H, Ar); 13C NMR (C6D6):
d 41.59 (d,
7.47 (d, J¼7.4 Hz, 1H, 5-Ar–H), 7.60 (s, 1H, 2-Ar–H); 13C NMR (C6D6):
JPC¼128.2 Hz, CH2P(O)), 52.94 (d, JPC¼6.4 Hz, P(O)OCH3), 53.16 (d,
JPC¼6.2 Hz, P(O)OCH3), 56.55 (s, 2ꢂm-C6H2(OCH3)3), 60.99 (s, p-
C6H2(OCH3)3), 71.97 (s, OCH2Ph), 78.94 (s, CHOBn), 102.47 (s,
OCH2O), 105.76 (s, 2ꢂo-C6H2(OCH3)3), 109.44 (s, Ar–H), 109.87
(s, Ar–H), 127.50 (s, m-Ph), 127.80 (s, p-Ph), 128.20 (s, o-Ph), 132.44
(s, p-C6H2(OCH3)3), 138.55 (s, C–C(O)), 139.25 (s, ipso-Ph), 139.68 (s,
C–CHOBn), 140.78 (s, ipso-C6H2(OCH3)3), 147.53 (s, C–OCH2O),
151.67 (s, C–OCH2O), 154.77 (s, 2ꢂm-C6H2(OCH3)3), 194.41 (d,
JPC¼6.0 Hz, C]O); MS (CI) (m/z): 558 (0.2%, Mþ), 541 (2,
MþþH(ꢁH2O)), 451 (100, MþþH(ꢁBnOH)). Anal. C28H31O10P re-
quires: C, 60.21%; H, 5.59%. Found: C, 59.92%; H, 5.50%.
d
38.72 (d, J¼128.8 Hz, CH2P(O)), 53.31 (d, J¼6.0 Hz, 2ꢂP(O)-
(OCH3)2), 102.57 (s, OCH2O), 108.61 (s, 2-Ar–H), 109.56 (s, 5-Ar–H),
126.92 (s, 6-Ar–H), 132.70 (s, C–(C]O)), 149.22 (s, COCH2O), 153.05
(s, COCH2O), 190.11 (d, J¼6.1 Hz, C]O); MS (CI) (m/z): 273 (100%,
MþþH), 257 (4, MþþH(ꢁO)); HRMS (CI) (m/z): calcd For C11H13PO6:
272.04497, found: 272.04442.
3.3.5. Dimethyl 2-oxo-2-(3,4,5-trimethoxyphenyl)
ethylphosphonate (10)
A light-yellow oil; Rf¼0.11 (hexane/ethyl acetate 1:1 v/v), 0.29
(hexane/ethyl acetate 1:4 v/v); IR (film) n
/cmꢁ1: 2953 (m), 2844 (m,
O–CH3),1675 (s, C]O),1585 (s),1506 (m, C]C),1459 (m, C]C),1417
(m),1336(vs, C(O)–CH2),1257(s, P]O),1228(vs, P–O–C),1032(vs, P–
3.3.2. Diethyl 2-(6-(benzyloxy (3,4,5-trimethoxyphenyl) methyl)
benzo[d][1,3]dioxol-5-yl)-2-oxoethylphosphonate (8b)
O–C), 808 (m); 31P NMR (CDCl3): 22.00; 1H NMR (CDCl3):
d d 3.61 (d,
A light-yellow oil; Rf¼0.58 (ethyl acetate); IR (thin film)
n
/cmꢁ1
:
J¼22.3 Hz, 2H, CH2P(O)), 3.79 (d, J¼11.1 Hz, 6H, P(O)(OCH3)2), 3.92 (s,
2982 (m), 2936 (m, O–CH2–O), 2838 (w, O–CH3), 1677 (m, C]O),
1591 (m), 1506 (s), 1487 (s), 1456 (m, C(O)–CH2), 1419 (m), 1330 (m),
1242 (vs, P]O),1127 (vs, CH–O–CH),1036 (vs, P–O–C), 968 (m), 791
9H, C6H2(OCH3)3), 7.30 (s, 2H, 2ꢂo-C6H2(OCH3)3); 13C NMR (CDCl3):
d
37.80 (d, J¼131.1 Hz, CH2P(O)), 53.22 (d, J¼6.5 Hz, 2ꢂP(O)(OCH3)2),
56.31 (s, 2ꢂo-C6H2(OCH3)3), 60.93 (s, p-C6H2(OCH3)3), 106.62 (s,
2ꢂo-C6H2(OCH3)3), 131.45 (s, ipso-C6H2(OCH3)3), 143.22 (s, p-
C6H2(OCH3)3),153.01(s, 2ꢂm-C6H2(OCH3)3),190.35(s, C]O); MS (CI)
(m/z): 319 (100%, MþþH). HRMS (CI) (m/z): calcd for C13H19PO7:
318.086842, found: 318.08656.
(w), 738 (w), 701 (w); 31P NMR (C6D6):
d
20.05; 1H NMR (C6D6):
d
0.99 (t, J¼7.1 Hz, 3H, P(O)OCH2CH3), 1.01 (t, J¼7.0 Hz, 3H,
P(O)OCH2CH3), 3.23 (d, J¼2.3 Hz, 1H, CH2P(O)), 3.35 (d, J¼1.3 Hz,
1H, CH2P(O)), 3.49 (s, 6H, 2ꢂm-C6H2(OCH3)3), 3.83 (s, 3H, p-
C6H2(OCH3)3), 3.83–3.97 (m, 4H, P(O)(OCH2CH3)), 4.62 (s, 2H,
OCH2Ph), 5.17 (s, 1H, OCH2O), 5.22 (s, 1H, OCH2O), 6.59 (s, 1H,
CHOBn), 7.06–7.19 (m, 3H, m-, p-Ph), 7.09 (s, 2H, 2ꢂo-C6H2(OCH3)3),
7.35 (s, 1H, Ar), 7.34–7.39 (m, 2H, o-Ph), 7.47 (s, 1H, Ar); 13C NMR
Acknowledgements
Financial support by the Ministry of Science and Higher Edu-
cation in 2007–2010 (Grant N204 022 32/0620) is gratefully
acknowledged.
(C6D6):
d
16.99 (d, J¼5.7 Hz, CH3, P(O)(OCH2CH3)2), 56.59 (s, CH3,
2ꢂm-C6H2(OCH3)3), 61.12 (s, CH3, p-C6H2(OCH3)3), 63.13 (d,
J¼8.8 Hz, CH2, P(O)(OCH2CH3)2), 72.13 (s, OCH2Ph), 79.13 (s,
CHOBn), 102.54 (s, CH, OCH2O), 106.05 (s, CH, 2ꢂo-C6H2(OCH3)3),
109.57 (s, Ar–H), 110.16 (s, Ar–H), 127.49 (s, m-Ph), 127.81 (s, p-Ph),
128.18 (s, o-Ph), 132.71 (s, p-C6H2(OCH3)3), 138.71 (s, C–C(O)),
139.49 (s, ipso-Ph), 139.85 (s, C–CHOBn), 140.91 (s, ipso-
C6H2(OCH3)3), 147.64 (s, C–OCH2O), 151.74 (s, C–OCH2O), 154.92 (s,
2ꢂm-C6H2(OCH3)3), 194.57 (d, J¼6.4 Hz, C]O); MS (CI) (m/z): 586
(0.4%, Mþ), 569 (5, MþþH(ꢁH2O)), 479 (100, MþþH(ꢁBnOH)). Anal.
C30H35O10P requires: C, 61.43%; H, 6.01%. Found: C, 61.49%; H, 6.10%.
References and notes
1. Miko1ajczyk, M.; Ba1czewski, P. In Topics in Current Chemistry; Majoral, J.-P., Ed.;
Springer: Berlin, Heidelberg, 2002; Vol. 223, pp 161–214; Nicolaou, K. C.; Ha¨rter,
M. W.; Gunzner, J. L.; Nadin, A. Liebigs Ann./Recueil 1997, 1283–1301.
2. Jacobson, H. I.; Griffin, M. J.; Preis, S.; Jensen, E. V. J. Am. Chem. Soc. 1957, 79,
2608–2612; Cotton, F. A.; Schunn, R. A. J. Am. Chem. Soc. 1963, 85, 2394–2402.
3. Mathey, F.; Savignac, P. Tetrahedron 1978, 34, 649–654.
4. Genov, D. G.; Tebby, J. C. J. Org. Chem. 1996, 61, 2454–2459; Ba1czewski, P.;
Pietrzykowski, W. M. Tetrahedron 1996, 52, 13681–13694; Truel, I.; Mohamed-
Hachi, A.; About-Jaudet, E.; Collignon, N. Synth. Commun. 1997, 27, 297–302.
5. (a) Obayashi, M.; Ito, E.; Matsui, K.; Kondo, K. Tetrahedron Lett. 1982, 23,
2323–2326; Piettre, S. R.; Girol, C.; Schelcher, C. G. Tetrahedron Lett. 1996, 37,
4711–4712; Faucher, A.-M.; White, P. W.; Brochu, C.; Grand-Maitre, C.; Rancourt,
J.; Fazal, G. J. Med. Chem. 2004, 47, 18–21; (b) Snyder, C. D.; Bondinell, W. E.;
Rapoport, H. J. Org. Chem. 1971, 36, 3951–3960; (c) Ganzhorn, A. J.; Hoflack, J.;
Pelton, P. D.; Strasser, F.; Chanal, M.-Ch.; Piettre, S. R. Bioorg. Med. Chem. 1998, 6,
1865–1874; Colvin, E. W.; Hamill, B. J. J. Chem. Soc., Perkin Trans. 11977, 869–874;
Mualler, E. L.; Modro, A. M.; Modro, T. A. Org. Prep. Proced. Int. 1999, 31, 216–220.
6. (a) Lignans: Chemical, Biological and Clinical Properties; Ayers, D. C., Loike, J. D., Eds.;
Cambridge University Press: Cambridge; New York, NY, 1990; Coleman, R. S.;
Gurrala, S. R.; Mitra, S.; Raao, A. J. Org. Chem. 2005, 70, 8932–8941; (b) Robinson, R.
Proc. Univ. Durham Phil. Soc. 1927–1928, 8, 14–59; Haworth, R. D. Ann. Rep. Prog.
Chem. 1936, 33, 266–279.
7. Corey, E. J.; Suggs, J. W. Tetrahedron Lett. 1975, 2647–2650; Piancatelli, G.; Scettri,
A.; D’Auria, M. Synthesis 1982, 245–258; Vanden, E. J. J.; Mayence, A.; Maques-
tiau, A. Tetrahedron 1992, 48, 463–468; Cainelli, G.; Cardillo, G. Chromium Oxi-
dations in Organic Chemistry; Springer: New York, NY, 1984.
8. Regen, S. L.; Koteel, Ch. J. Am. Chem. Soc. 1977, 99, 3837–3838; Shaabani, A.;
Mirzaei, P.; Naderi, S.; Lee, D. G. Tetrahedron 2004, 60, 11415–11420.
9. Shaabani, A.; Lee, D. G. Tetrahedron Lett. 2001, 42, 5833–5836.
10. Kiasat, A. R.; Kazemi, F.; Nourbakhsh, K. Synth. Commun. 2005, 35, 1555–1558;
Santaniello, E.; Ponti, F.; Manzocchi, A. Synthesis 1978, 534; Lou, J.-D. Synth.
3.3.3. Dimethyl 2-(6-bromobenzo[d][1,3]dioxol-5-yl)-2-
oxoethylphosphonate (9a)
A light-yellow oil; Rf¼0.33 (petroleum ether/acetone 1:1 v/v);
IR (KBr) n
/cmꢁ1: 3433 (br w), 2961 (w), 2902 (w, O–CH2–O), 2855
(w, O–CH3), 1691 (s, C]O), 1612 (m, C]C), 1510 (m, C]C), 1496
(m, C]C), 1484 (m), 1343 (m), 1263 (s, P]O), 1238 (P–O–C), 1034
(vs, P–O–C), 1022 (vs), 806 (m); 31P NMR (CDCl3):
d
22.34; 1H
NMR (CDCl3):
J¼11.2 Hz, 6H, P(O)(OCH3)2), 6.03 (s, 2H, OCH2O), 7.02 (s, 1H, Ar–
H), 7.07 (s, 1H, Ar–H); 13C NMR (CDCl3):
d
3.66 (d, J¼22.3 Hz, 2H, CH2P(O)), 3.76 (d,
d
40.73 (d, J¼129.5 Hz,
CH2P(O)), 53.10 (d, J¼6.5 Hz, P(O)(OCH3)2), 102.54 (s, OCH2O),
109.83 (s, 2-Ar–H), 111.99 (s, C-Br), 113.76 (s, 5-Ar–H), 133.55 (s,
C–(C]O)), 147.44 (s, C–OCH2O), 150.72 (s, C–OCH2O), 193.25 (d,
J¼6.6 Hz, C]O); MS (CI) (m/z): 352 (98%, Mþ
(
81Br)), 350 (100,
Mþ
(
79Br)), 271 (24, Mþ(ꢁBr)); HRMS (CI) (m/z): calcd for
C11H12PBrO6: 349.9555, found: 349.95506.